0001104659-21-031097.txt : 20210303 0001104659-21-031097.hdr.sgml : 20210303 20210303070502 ACCESSION NUMBER: 0001104659-21-031097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210303 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 21707205 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 8-K 1 tm218538d1_8k.htm FORM 8-K
0000885725 false 0000885725 2021-03-03 2021-03-03 0000885725 us-gaap:CommonStockMember 2021-03-03 2021-03-03 0000885725 bsx:SeniorNoteDue2027Member 2021-03-03 2021-03-03 0000885725 bsx:A550MCPSSeriesAMember 2021-03-03 2021-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

     

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

     

 

Date of Report (Date of earliest event reported): March 3, 2021

 

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   1-11083   04-2695240
(State or other jurisdiction of
incorporation)		   (Commission File Number)   (IRS Employer Identification No.)

 

300 Boston Scientific Way, Marlborough, Massachusetts   01752-1234
(Address of principal executive offices)   (Zip Code)

 

(508) 683-4000

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, $0.01 par value per share   BSX   New York Stock Exchange
0.625% Senior Notes due 2027   BSX27   New York Stock Exchange
5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share   BSX PR A   New York Stock Exchange

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

 

ITEM 8.01 OTHER EVENTS.

 

On March 3, 2021, Boston Scientific Corporation (the "Company") announced that it has entered into a definitive agreement to acquire Lumenis LTD. (“Lumenis”), a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of $1.07 billion subject to closing adjustments. The Company will exclusively acquire the Lumenis global Surgical business unit of innovative laser systems and fibers used for urology and otolaryngology procedures, as Lumenis plans to separate its Aesthetics and Ophthalmology business units into a new entity prior to the close of the acquisition. The Company expects to complete the transaction in the second half of 2021, subject to customary closing conditions.

 

A copy of the Company's press release announcing the signing of a definitive agreement to acquire Lumenis is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however, that information on or connected to our website or the website of any third-party hyperlinked from or referenced in the Company's press release included as Exhibit 99.1 to this Current Report on Form 8-K is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our business plans, regulatory approvals, the closing of the acquisition and timing of such closing, product development and product performance and impact. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

 

Use of Non-GAAP Financial Measures

 

To supplement our consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share that excludes certain charges and/or credits, such as amortization expense, acquisition-related net charges (credits) and investment impairment net charges (credits). These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. For further information regarding our non-GAAP measures, see Part II, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report on Form 10-K, which we may update in Quarterly Reports on Form 10-Q we have filed or will file hereafter.

 

ITEM 9.01.FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)  Exhibits

 

 

 

 

Exhibit No.   Description
99.1   Press Release issued by Boston Scientific Corporation, dated March 3, 2021
104   Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 3, 2021 BOSTON SCIENTIFIC CORPORATION
       
    By: /s/ Vance R. Brown
      Vance R. Brown
      Vice President and Chief Corporate Counsel

 

 

 

 EX-99.1 2 tm218538d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1 

 

 

boston scientific ANNOUNCES AGREEMENT TO Acquire LUMENIS LTD. Surgical Business from baring private equity asia

 

Acquisition of a leading laser technology to expand global kidney stone management portfolio

 

MARLBOROUGH, Mass., March 3, 2021– Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of $1.07 billion, subject to closing adjustments. BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. With 2021 net sales anticipated to be approximately $200 million, the Lumenis surgical business includes premier laser systems, fibers and accessories used for urology and otolaryngology procedures. Foundational to its urology portfolio is the proprietary MOSES™ technology, which has demonstrated differentiated clinical outcomes and efficiency in the management of patients with kidney stones. 

 

Worldwide, more than one in 10 adults develop kidney stones each year with up to 50 percent of patients having a repeat stone within five years of the first occurrence.1,2 ,3 ,4 While some kidney stones may pass through the urinary tract naturally, complex or larger stones require intervention to remove them from the urinary tract. This can be done through surgery or less invasive procedures, such as lithotripsy which uses a small telescope-like device, a ureteroscope, to locate the stone and a laser to break it apart. Laser lithotripsy is a leading modality for minimally-invasive surgery of kidney and urinary stones, whether through flexible ureteroscopy or percutaneous nephrolithotomy.

 

“The MOSES laser technology, paired with our LithoVue™ Single-Use Digital Flexible Ureteroscope and comprehensive kidney stone management portfolio, will enable execution of our strategy for our stone franchise,” said Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, Boston Scientific. “With double-digit compound annual growth from 2015 to 2019, we look forward to adding the innovative Lumenis laser portfolio, talented employees and surgical laser center of excellence to our organization. The acquisition will expand our global footprint throughout Europe and Asia and accelerate the delivery of our robust stone management offerings to more urologists – ultimately serving more patients worldwide – while also improving our top-line growth and margins.”

 

Boston Scientific has had a relationship with Lumenis for more than 20 years and currently sells the Lumenis urology laser portfolio in the U.S. and Japan through a distribution arrangement. Upon completion of the acquisition, Boston Scientific will sell these lasers and fibers – as well as the otolaryngology laser portfolio – to all geographies including high-growth regions like China.

 

“We take great pride in our heritage of innovation in surgical laser solutions which are helping millions of patients worldwide,” said Tzipi Ozer-Armon, chief executive officer, Lumenis. “Notably the proprietary, patent-protected MOSES technology has revolutionized urology laser procedures by improving the clinical efficacy and efficiency for kidney stones. We are confident that Boston Scientific, as a global leader in urology, and our long-time commercial partner, is the best organization to carry this legacy forward.”

 

 

 

 

The company expects to complete the transaction in the second half 2021, subject to customary closing conditions. The impact to adjusted earnings per share is expected to be immaterial in 2021, approximately two cents accretive in 2022 and increasingly accretive thereafter. On a GAAP basis, the transaction is expected to be dilutive in 2021 and less dilutive or increasingly accretive thereafter, as the case may be, due to amortization expense and acquisition-related net charges.

 

Lumenis LTD is headquartered in Yokneam, Israel. Additional information about this transaction is available on the events and presentations section of the Boston Scientific investor relations website. 

 

About Boston Scientific

 

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding the financial and business impact of the transaction, product launches and product performance and impact. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; the closing and integration of acquisitions; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

 

Use of Non-GAAP Financial Measures

 

To supplement our consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income and adjusted net income (earnings) per share that excludes certain charges and/or credits, such as amortization expense and acquisition-related net charges (credits). These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. For further information regarding our non-GAAP measures, see Part II, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report on Form 10-K, which we may update in Quarterly Reports on Form 10-Q we have filed or will file hereafter.

 

 

 

 

CONTACTS:

Kate Haranis

Media Relations

508-683-6585 (office)

kate.haranis@bsci.com

 

Susie Lisa, CFA

Investor Relations

(508) 683-5565

BSXInvestorRelations@bsci.com

 

 

1 Durbin JM et al; Clinical Nephrology; V.77; 2012; p204; DOI:10.5414/CN107242.

2 Jungers P et al; American Journal of Kidney Diseases; V.44; No.5; 11/04; p799.

3 Santos-Victoriano M et al; Clinical Pediatrics; V.37; 10/98; p583.

4 S. R. Khan, et al; Nature Reviews Disease Primers, vol. 2, p. 16008.

 

 

 

 

 EX-101.SCH 3 bsx-20210303.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 bsx-20210303_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 bsx-20210303_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Common Stock [Member] Senior Note due 2027 [Member] 5.50% MCPS, Series A [Member] Statement [Table] Entity Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 bsx-20210303_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 tm218538d1_ex99-1img001.jpg GRAPHIC begin 644 tm218538d1_ex99-1img001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#?\;_%;7?# M?B^^TBRM=.>"W\O:TT;ECNC5CDAP.K'M7.GXY>*NUAH__?J7_P".5@_%MF'Q M/UC!/_+'_P!$QUQ@E8>]=L*<'%:')*GGXZ^*A_S#](_[\R__'*3_A>W MBC_GPTC_ +\R_P#QRO,Q-ZBG>8K?_7JO9P["]I+N>E_\+V\3_P#/AH__ 'YE M_P#CE'_"]O$__/AI'_?F3_XY7FH56[4GE9Z'\Z/90[![27<],_X7KXG_ .?' M2/\ OS+_ /'*7_A>OB?_ )\-(_[\R_\ QRO,?+8>])@CL:?LH=A>TEW/4!\< M_$W>QTC_ +\R?_'*D3XY^(?X['2_PAD_^.5Y6*<,^M/V4.P>TGW/65^-VNMT MM-+S[Q2?_%T[_A='B'M::3_WZD_^+KR7E?]^I/_BZ\I6>0=\_6G_:,_>4?A3]E3["]I/N> MJCXR^(O^?+2_^_4G_P 72CXR>(?^?/2_^_4G_P 77ERRH>C%:E5F(^67-'LJ M?87M9]STW_AF?]^I/_BZ\S\R<=@:7 MSY!]Z.G[*GV#VL^YZ:/C!X@/_+GIG_?J3_XNG?\ "W_$'_/GIG_?J3_XNO,U MN_6,_A4@NXN^1]11[&GV%[6IW/2/^%O^(/\ GSTS_OU)_P#%TA^+WB+M9Z7^ M,4G_ ,77G8N(CT<5(LBGHP/XT>QI]@]K/N=\?B]XF'_+EI)_[9R?_%TP_&'Q M,/\ F'Z9_P!^I/\ XNN(# T\8]:?L:?83JS[G:?\+C\2=['3!_VRD_\ BZ/^ M%R^(.]EIG_?J3_XNN,S1Y:MU4'\*/84^P>UGW.S'QFU_/_'EIO\ WZD_^+IX M^,FN][+3O^_3_P#Q=<1]GB/\./I1]D0]"11[&GV%[:?<[C_A<>N_\^FF_P#? MJ3_XNE_X7#KO_/KIG_?J3_XNN$-D3]UQ^(I#92+TP?QI^PI]@]M/N=\/B_KW M_/KI?_?N3_XNC_A;VO'I:Z7_ -^W_P#BZ\_-I+W0TTP$=5(H]C3[![:?<]$' MQ;U\_P#+IIG_ '[D_P#BZ0_%OQ#VM-+_ ._=B''K3@F.[?G1[&GV%[ M:IW/0#\7/$G:STK_ +]2?_%TW_A;OB4?\N6E_P#?J3_XNN$WD#@FF>9+GKD> MXH]A3[![:IW.]_X6_P")1_RXZ7_WZD_^+I#\8/$@_P"7#3/^_4G_ ,77""27 M^Z*7SB.J4_84_P"47MJG<[K_ (7%XC_Y\M,_[]2?_%T?\+B\1?\ /GI?_?J3 M_P"+KA_-0_P$4;XCZCZBCV%/^4/;5.YW'_"XO$/_ #YZ7_WZD_\ BZ/^%Q>( M?^?/2_\ OU)_\77#[8R/O+^- A4]"OYT_84_Y1>VJ=SN/^%Q^(?^?/2_^_4G M_P 71_PN+Q#_ ,^6E_\ ?J3_ .+KA_LX]#33 /<4>PI_RA[>IW.Z_P"%Q>(? M^?+2_P#OU)_\71_PN+Q#_P ^>E_]^I/_ (NN%\@^M)Y+>U'L*?\ *+V]3^8[ MS_AI_,=_P#\+@\0_P#/GIG_ 'ZD_P#BZ/\ A(/^?/3/^_4G_P 72_\ "X/$'_/GIG_?J3_XNN!VT8H^ MKTOY2?;U?YCOO^%O^(/^?/3/^_4G_P 71_PM_P 0?\^>F?\ ?J3_ .+K@<4$ M4?5Z7\HOK%7^8[[_ (6_X@_Y\],_[]2?_%TO_"W_ !!_SYZ9_P!^I/\ XNN M HQ3^KTOY0^L5?YCO_\ A;WB#_GSTS_OU)_\71_PM[Q!_P ^>F?]^I/_ (NN M!HQ1]7I?RA]8J_S'??\ "WM?_P"?/3/^_4G_ ,72CXO:_G_CSTW_ +]2?_%U MP&*6G]7I?RB^L5?YCOO^%O:__P ^>F?]^I/_ (NC_A;VO_\ /GIG_?J3_P"+ MK@:3%'U>E_*'UBK_ #'?_P#"WM?_ .?/3/\ OU)_\71_PMW7_P#GSTS_ +]2 M?_%UP&*7M1]7I?RA]8J_S'?_ /"W=?\ ^?/3/^_4G_Q='_"W=?\ ^?/3/^_4 MG_Q=)K?S,[W_ (6[K_\ SYZ;_P!^I/\ XNC_ (6[K_\ SYZ9 M_P!^I/\ XNN!--H^K4?Y4+ZS6_F9W_\ PMW7_P#GSTS_ +]2?_%T?\+>\0?\ M^>F?]^I/_BZX"DH^K4?Y4'UFM_,SO_\ A;WB#_GSTS_OU)_\71_PM_Q!_P ^ M>F?]^I/_ (NN I,4?5J/\J#ZS6_F9W__ M_Q!_SYZ9_WZD_^+H_X6_X@_Y\ M],_[]2?_ !=?XI-M'U:C_*@^LUOYF>@_\+D\0_\ /GI?_?J3_P"+ MI/\ A(O^?+2_\ OU)_ M\71_PN3Q%_SY:7_WZD_^+KSTTE'U:C_*@^LUOYF>A_\ "Y/$7_/EI?\ WZD_ M^+I#\9?$7_/EI?\ WZD_^+KSS%)BCZM1_E0?6:W\S/0_^%S>(O\ GRTO_OU) M_P#%TG_"YO$7_/EI?_?J3_XNO/<4FTFCZM1_E0?6:W\S/0_^%S^(O^?+2_\ MOU)_\72?\+G\1_\ /EI7_?J3_P"+KS[8:-GO2^K4?Y4'UFM_,SVSX??$'5O% M>O3V%_;V4<4=JTP,".&W!D'=CQ\QKTFO#?@T /&%W_UX/_Z,CKW*O+Q<(PJV MBK(]7"3E.E>3NSY@^+;$?$[6!_UQ_P#1*5Q6X=U%=K\6U)^)VL'_ *X_^B4K MB<5O#X49S^)B_*?448]"*2EQ5$AR.U*';UJ6U@-Q=PP!MOFNJ9],G&:]@_X4 M)-W\0Q_^ A_^+J93C'#-5BM)YA<0S1[XIU3 M:&]1C/!']16KX%^&TGC73[J[34UM%@E\K:8=^[@'/4>M-S2CS=!%/$4^D/Y.!3$4]2.!Z MT[)8\]*8B99F7A3^=/%PQZ\TQ$ST%3+;$U1+&AU;KQ3]JD=HJ92C%78XIR=D<>T)QE>141!'6O7E^",ZG(U] M,?\ 7J?_ (JF3_!*["DP:U"S>CP%1^8)K/V]/N7[&?8\E$C+T8CZ&I1/J*[#XC>#M$\.:)87NDI,#<2[27D+97:2.M>< T0FIJZ"<'%V9N+ M<(Q^5P?QJ4/6"I%/$K*?E)'T-7<@WMYIP&:Q4O95_B)^M3KJ<@_A!IB-3R4/ M5133:QG^\/QJDNIC^*,_@:F34(3U)'U% $WV,=G_ #%(;5AT"&G)=1-TD7\Z MF5P>AS3$5##(.L6?I4150?F1A6H#3^#UH$8QCC/=A^%'D+V?\Q6SY,;=47\J M:;.$] 1]#3 R/LY/1E_.D^RR=AGZ&M5K'^Z_YBH_L,@/&#]#0(SA#*.BL*/W MB]2WXU?,,L?56%,R^>N?J*!%0.WH#^%.$GJOY&K/7JBG\*"L9ZQX^AI@5]ZY MZ$4N5/>IC#$>A84AMU/W9!^(H$1[%/\ =-)Y*GM3S:R=MK?0TGDRI_"WX4P& M>0.V:;Y!SP14FYP>?U%.#GN* (3"P[4W80.0:MAU[@BE^4]Q3)*6*3;FKWEJ M>P--\A?2@"GMHVU:-OZ$TGD-VP:8BOMI,5.8F'8TW;0!%BC%2[:3;3$,I,5) MBDQ0 S%&,4\BDQ0 W%&*=BC%,0E%+BE - F-Q0*=MHZ4Q"&DZTIHIC"DI<4E M !12XHQ0(2BG8I#0)C:,4M&* &T4N*,4 -Q1BG8HQ0 RBG[:,4 1XHQ3\4F* M &8HQ3\4F* &4F*?BC% #"*3%28HVT 1XI,5+MHV^U $.VEV5+MXHVT 0[:- MH]*G\MO[II?*- $&WVI"*L^5[T>6!VH K;2>U&SU-62!WIA*CO0!WGP=4#Q= M=]?^/!__ $9'7MU>*?!]@?%UV!_SXO\ ^C(Z]KKQL;_&^2/9P7\'YL^9OBQ& MQ^)6KL._D\?]L4KARISSG\J[SXJ3*OQ*U93CCR>2/^F*5R7#+T4UO!>ZB)_$ MRB$ &3^M(67L*N-$&Y&/Q%1-&R]4'X"JL201R/%(LB,5=2"K#J".:^B?@[KN MJ:]H>HS:K>R74D=R$1I,9 V@XKYY) _@'Y5[M\"#GP[JG '^EC_T 5A72Y+F MM%^\=7X^\*1^,?#CVJ%5NX6,EM)Z..JGV/0__6KP'PIKNMZ%KEMIUK>SVL/#OB2-_&WB'PY,P$L,PGM\G[R,BE@/HQS_P+VK@?B+X6 M&E^/])UNVB_T:_O(O-P.%F##/YCGZ@UE3=KPD:5%?WD>@?$W4[W1_ ]U>Z?< MO;W*21A9$Z@%P#7S?_]=(O M_0Q6=\(_"=MI/AV/7+B)3?7JEU=AS'%V ],]3]1Z44YJ$.;J$XN4K'ED7PM\ M8S0>:NC.H(R%>:-6_(MFN>U/0M3T6[%KJ5E-;3'E5D7&[Z'O^%>JW'QQF7Q MR0Z9"VE++MW%CYK+G&X'H/7&/QKT7Q9HEKXI\+2 (LDHC%Q:28Y#@97'L>A] MC5^UG%KF6Y'LXR3Y6?.P\$^*0,_V!J./^O=O\*Q#E'*.I# X((Y!KZB\$^+H M_&.BR7RVOV62*8PO%OWXP 0+^(?#*1?%DZ0J,8[N\C=<=-KD,?RR1^ M%7"JVVI+8F=-))HQG\)>(8[0SMHM\L(7>SF!L 8SGI65!;F>58T0L[$!549) M)["OK:013)+:-@YCPR_[)R/Z&OGKP/HK2?$>VL)%)%I<.SY'_//)_F!3I5^9 M-M;"J4N5I+J4E\&Z_#&TLFD7BHJEF9H2 !ZU:TGPSJ.K-ML[227'4J.!]2>* M]G\8>(H](@@L##YLNH!XA\V-@QC)X/J*UDBAT#0BEM 6CMHLA%ZL0._O6;Q$ MK7MN6J$;VN>+W7PY\0PQE_[/+ =D=6/Y UR%S9R6T[1RHTVM@@!4E\9Z^IKR3QO)%<^*[^>"1)(WD!#*<@\#O6E*I.3<9(SJ M0BDG%G9_&(L/!^F;6(_TE>A_Z9M7CVF:SJ.DW2W%E>SPR(P8;7(!QV(Z$>U> M]?$#PQ?^*?#EC::<81)'*LC>:VT8V$>A]:X?2?@OJ1O$DU:^MHK92"Z0%F9A MW&2 !]:FE4@J=I%5(3<_=-KXN)'J'@'2]4= LWFQL/4!T)(_0?E7B,2R22!( MU9W8X"J,D_A7I_Q:\56>H_9=!TR1)+>T;?,Z'*[P-JJ/7 )_.MGP_:Z?\-_ M4?B*\M1/JMZ%* ]1N&50'L,#)_\ U4ZX9PP(([$5Z#8_&+Q%'JBS7BVTUF6^>!(]N%_V3US][=<_3%=-XPM+'QI\/H MO%-M ([R%-[8Z[0<.A/< Y(^GO5^TG%KG6C(]G%I\KV/(;.QO;^3R[.UGN'_ M +L,9=QPWH=HQSCJ<\UN^"OB9J^K^([?2]5AMWBN2562--I1L$CO@CC%.4ZBN[:" MC&#LKZGDRFK=G8W>H2^396TUQ)UV11EC^E=-\4=%M=%\6G[(HCBNH1.8U& K M$D''Y9_&NYO;O_A77PXL)=+M8GNKDQB25UR-S*6+''7I@"FZWNKE6K$J7O-- M['E-WH6KZ>A>\TN\@0=6DA8 ?CBJ2NR'*L1]#7JW@GXEW6J:G-:^(;JPAM1" M661P(\MD#&2<="?RJIX$\.Z??ZQK'B&]6-]/L[B3R!C*$@EBWH0!C'U]J7MI M1OSK8?LE*W*]SC[31_$5S")K?3+Z6(C(80,01['%5Y;F]LIS#=V[12KU21"K M#\#74:A\7-I6BN M1M_A=1DJ#_=8=O?VINK.-G-:,2IPE=1>IY@FJK_%&1]#5B/4H&_B(^HK!#4X M&N@P.E6XCD^ZZGZ&I5?-I93[BK4=S%)]V13^- B MLUA*/N[6^E1/:2KUC;\JUU:GY]Z8C \O!IP##H3^=;ICC?[RJ?J*C:Q@;HI7 MZ&@#'W/CG!^HHPK=8A^'%:ITX?P/^!%1-93+T4-]#3$9WD1-V9?UI#:K_#*O MX\5<:-U^\A'U%1E,T"*QM)!R #]#3-LJ=0P^HJUL(Z$CZ4H,B_Q$_6F!5$A[ M@4X2*>H(JP6!'SQJWX4W9">JLM B+*GH:"@/4 U(;93]R0?0TTVTJ]!GZ&@" M,PJ>V*8;?T/YU,?,4X(/XBE#\\BF(JF!AVS]*:8R.H(J\"I]J7:"..: ,[92 M;*T#$I'(IAMQV)%,12VT;:LFW;M@TPQL.H(H AQBC%2[*-E B+%)BI2M)LI@ M,Q2?A3]IHVTP(\48%/(R:3;0(;BEQ3]N*2@!I&:;BI,48H$R/%%2;11B@"/% M:>A"U?5+>WN[-+E)Y4C^9W4IEL$C:1Z]ZS\5?T0?\3[3O^OJ+_T(5%3X67#X MD=EXUTC0/"MU9)#HRSI.K,P>XD!&".AS[TZ#P7HGB?PZVI:"9[6Y3(-O*^]0 MP'W<]>>Q_2M3XF:1=ZK>Z8+40_*C@^9,D?4C^\1FGV4L7P[\(R)/0E!>TDI1]T\B*D$@C!'%)MK5T?1;[7[_P"S M6:!GQND=CA4'JQJ]#X=TZ\O18VFOP27;':@:!UC=O0/_ "XYKO=6*T9P*FWJ MCF\48K6C\/:B^N_V,T/EW@8A@YP% &2Q/ICG-7K/PY8:E>I966O0/<,P4"2! MT5O]UN<_CC--U8+J)4Y/H-DU56W,%;')(P >.F:S_ !-I$8US4IDU&VEDDO)/W$:OO7+G@Y4#CIP:A5HN M?(6Z,E#G.8Q25U5QX3MM*BA.M:FEG/,N]8 AD8+ZMC&*CU#PY_9GV6:2XMS8 M70S#>@,8SQGG )!]L52K0?4ETIKH\N-&&J6M[: M7%NWW#&6 (W88DL!@#!)/M3]/\%V^LVLYTK7;:ZNX!EX5B95_!CU'OC%1]8I M]RO85-K'$BW/<@4[[.HZDFGW)DM+F6WGB,:Q[F@"8K[TTK[U%O;UIIDQU:@#T?X.C_BKKOG_EP?\ ]&1U[=7AOP:? M=XPNQ_TX/_Z,CKW*O&QW\;Y(]G _P?FSYA^+1_XN=K'_ &Q_]$I7&HY4Y%=E M\6O^2G:QS_SQ_P#1*5Q@]>*VA\*)G\3+"7&>H-3JP?[I-4@3ZBE!)ZL/KFK1 M!;:!6] ?8U[?\#8S%X?U,9SFZ!_\<%>(6BR3W,4 *$R.$!)]3BOI+X?>%+SP MEIMW:WD\$K33"13"20!@#G('I6&(:Y;&M%/FN>.^.=1NM'^+&HZC92M'<03( MRD=_D7@^H/I7M1>T\=^#;:Z@"_O-EQ&">8Y48''X$$?2O./B=X'O5OM2\3-/ M;FUDD3$8)WC("^F.OO2?![Q"=-U.70KB3_1KL[X-Q^[(!R/Q _,#UJ)14J:E M'=%1;C-I]3MOB]_R3F]_ZZ1?^ABNET5(8?"NG+QY"V48Z<;=@_I7.?%S+?#R M] '_ "UB_P#0Q4OPTUR+7/!=I"7!N;.,6\Z'J-HPI^A&/UK&W[M/S-;^_8R? M[2^$_P#SST7_ ,!?_L:VT^(O@R&%8H]:ME1%"JJJP [=*\ZUKX):F=4F?2+ MNS:S=BR+.S*R ]N :?XFU_E.?SS^%?3LEO&;R*\8@-%$Z ^ MS%2?_0116]V=UU"E[T;=CE]+UL7/Q/UO3 V1%90@?522?_1H_*J'AO0_L?Q3 M\2797Y?+1T_[:G.?$/6/MOC65$D.VR585(/\0Y/ZG'X5Z!X M>^(.EZE:Q17TRVMYM ?S.$8^H/09]Z\0TVY;4?%%M+= 2&YO5:0,,AMSC/\ M.O;O%G@F#4='$.BV5C:W2R!]P0)E<'(R![UK54$HPD94W)MRB:VH^&-(UFW9 MU18W<96: @?CZ&O$?$VE3Z'K,MAK> /#6L>'TNO[3N$,YT^[3;+!(4;T/H1[$ M.%\+QZ)8IXD$OV)9 (1%O\ O;3_ '?;-<_\3/",GB*"SUW0X?M4[*%D M6+K+&1E6'KC^1]JOR:>/B!\/4TV63[/JMD0DJOUCG0;3N'HPS^?M2G-349/Y MA&+BY(Y3/PA]+S_R/4_C7QEX7U+P(-$TBXE9X?*6%'B<85,#J?:N#N?!7B6U MNS;2:)?-(#C,<+.I^C#C%.USP9K7AS2[:_U.W6)+AR@3=N9"!D;L<#/..>QK M7V<&U[U_F9\\DGH>D?%T?\45H7_71?\ T76UI*:1'\'+,:QO_LS[.IG\O=GE M\_P\_>K+^)EG=:KX!T2>QMY+A4,;L(E+$*T?!P.V3-OMOT,//PD]+S/_;:M5_&/@FP\'W^B M:1/*1LLRGN?>O.]8\!^(](OFMVTRXN4S\DUM$9%E1?G@Y3E\B[RR ?]#'_ *&U6O#/CS2; MS0H_#WBFWWVZJ(TG(+*5'3=CD$>H_2K'Q7T#4=1U[3[VVLYIK5(-DSQJ2$ 8 MDY].#63X^\!OI%U:OH&EWJ7%Q=6US:Z>T)!68%0[Y&, _CS6_X9U_3M5UWQ'H)=#%-<2/$, M\2*1M<#\1G\36=1R:<;W2+@HIJ5K-G+ _"?TN_\ R-6[H_B[P%X?L+BTTV>X M2*8EF5HY&R<8[_2O/];\ :YI%_+#'8W%U;AOW&WC,A$WRNP'7"]>G/.*V<*;6LW]YCSS3TC^!SK!2QVGC/%*%]Q3@0_3BI%N+8_>A(^C4Q&E'JO]]1]035N/48&QE\?4&L93:,>"X_&I5C MMSTDOZU ^ERC[N&_2K\ M4?2NA\S_:/YTI"N?F4&@1SOD&F M>4RG@G\*Z![5'^ZS+^.:@>QE'W'5OJ,4P,D.ZC!Y^HI#Y;?>B ]Q6@\,Z#YH MA]=H-0DGNB?]\B@12,$3?=)<>Y/^-*6MS_K+92?4,:8BB"K=\?6I/*[]:M>7:-T M0K_P*E6T7/R1L?=9,?TH$4C IZJ*C:TW?=)K4$:1_P"LBDQ[L/\ "I!-:_\ M/.4?0BE<#$-E*#PA-,-LXZJ?RKHU%L_0O^E*T4(ZB3\A_C1=BNCF3$1U!I/+ MKHC;6[=?,'T4?XU$^F0-RLKC_@'_ ->CF P#'32F*UI;)(^KMCUV_P#UZK-# M%_SU/XK5)B*!6C;5DPQ@_P"M'Y&D\J/_ )[K^1_PIC*^*3%6##'_ ,]T_(_X M4TPI_P ]D_7_ H$08J[8Z1J&J%A8V@J73-+_M#4[6U\U0)I M5C)&> 2!Z5U7CJ.6WU&/1[62.TTVWB79""5#$C)8XZG_ K*=1J:A'=FL()Q M1S6+D":V8ED9?7!'45J^(IM*M_'\]U>23(L30R1B&-6W853CEA@<5$IR3Y M&NG0N,(VYD^I;^+@)O=* &?WQ7VD7JF>Q6(,J2C(7)P5^A]* MJ>*?$V@^));=S/?6_DJR\01MG./^F@QTJ.W\9Z;H.DR6N@6KMNKMD!)] M<*3T[#I7/[.3H*GRN_Y'1SQ5=U.;3\SHO#VEVVEZ)XJCMB,I-/&K#JJJGRC\ M,FO+M/6&+4[1A+EA,A&#WW"M7PSXHFT6]NA>'[59WH(N4\P;B3GYA[\GZTEE M:^&M/U2*^;5YKF&"02I;+!M=L'(4L3CTSBM(1E3#-9N%;1M7:WNR=T2))@AAR,* MPSQ[5RP\5PZGXGN]1UF,FSEM'MD@B8$JIZ $]^ISZU4TR#P_I>JP:E_:\\ZV M\@FCMU@VNQ!R S%L#GK62I2C&VJ=NFS\C5U8RE?1JYU/P]MKG3_'6K6%TRM+ M! RLR_Q?.O/XCFLS0(8;OXMW:7&'6.[N716/\09L<>W7\*J^'/&"6'C2]UG4 M4'E7JLKB-@3'D@CZX Q536;O2+;5[C5]%U&XFOYKDW$1*B-8Y#=%CC"_3:#_,FNBABBN/@:QGP?*W- M&3U#><<8_/'XU@ZYJ6C>+)X;^[NSIMZ(Q'/'Y7FH^/XE(.1UZ'VIVHZS:WVA M6N@:<;B/1+/!N;C:IDD))(.W< !N.<$_RIN,G"$;6:W&I14YRO=,WFD9/@0K M(Q4D8)!QP9SFJ'P=;=KFH?\ 7N/_ $(4Q_$OA[_A!AX7,FI!1_RW\B+/^LW_ M '?,_#K5+P/XAT3PG=7-S.][-),IC")%'@*&R#DOUQU&/Q-2X2]E-K_\ 7T_\Z;#X4UB6TCNY(([6WD&4>[G2'=] Y!-==X?T M_2O%GQ'EOX3/+;#?=RQ7$:KAL@*O#'(R<\XZ5S/CBYN=2\8:D\L@*PS-#&I; MA50X [=,_C6T*DFU3CHTM3"4%9S>MV9.I:/J&D^6UY;[(Y?]7(CJZ/]&4D' M\ZS\UW>O>)=&OO!EKH>F:<;5TD620OMVA@.2"#DD^IQ7$>2HZR)^=;4I2DO> M5C*I&*?NNY#DT?C4I5!_$GYTTD#HR_G6AF, /93^-&UCW H+'^^M-.3_ ,M! M^M #M@[L:;F,>E-V _QBCRQW<4 >C_!APWC"[ _Y\'_]&1U[G7A7P751XQN\ M-G_B7O\ ^C(Z]UKQL=_&^2/9P/\ !^;/F#XM_P#)3]8_[8_^B4KBLFNT^+>? M^%GZQ_VQ_P#1,=<4,UM#X41/XF.!I0:2E%62302/!*DL9VNC!E/H0PU&]6:V<@L@A1WGO M5@MW&&BMUV!AZ$]-E.&X^M-V^XIR@I;H2DUL6]-U M*?2M3MK^W(\VWE65 W0D'.#[5VFM_%36M?T6XTR6VLX(YP%=HE8-C() RQZX MQ7 [3GGCZT[ '?\ *FX1;NT)2:5DR5)I(G#*Q5E.01Q@UVFF_%7Q38(L;W45 MVBC %Q&"?S&":X@2<<@&EW*:;BI;H2;6S/0-0^+WB2]MVAB%K9[A@O"AW?@6 M)Q6!HWC37=!$XT^\V?:'\R4O&KEF]H;;>$816B1\#TR1FJ-GXJU2SU>?58+R6&[N'+RNF,.2 MO6A0CV#F?<]'3XP:_P#9]FVS9\8\PPG/Y X_2N6USQ#J M?B.16U/4))E4Y6/A47Z*./QK#"D<@YIX8X&11&G"+ND$IR:LV=CH?Q&\0>'] M/2Q@DM[FWC&(A.F2@] 01Q]:Q]4\6:SJNNQZS)=>3>Q*%C>!=FQ02<>_4]M"I03ND#J3:LV==H'Q%\1:!:+:1317-N MO")P((./:JVO>./$'B JMU>>7"C!UA@&Q0PY!]3CW-SA>]A M.I*UKG6W/Q(\575E+:37RM%+&8WQ"@)!&#SCK4VF?$_Q1IL2Q&YCNXU& +F/ M);6 M1RFUN<6@1&*> :<(G[8/T-+Y,A/"TP& MTZCRI!U1J3!'8T"'@T\-BH0:<#3 LK*X_B./?FIA.O\ %&I_2J6XTX-3$RZ) M8NV]/H]2 M)/(OW78?C3 VH];D7AX8V_"KD6N6QXDMV'NK5SXNG_BVM]13Q<1G[T0_X#_] M>BPKG41:CI\O_+1T/HU6U\B0 K<<>XKD%>!NY7ZC_P"O4\6 3;3??LQD]UR*+OL%ET9S26V\U.(?+X3K70'3;7;\OF M(??%1'20#D29_6IYKARM&,!+W.[ZBGB"-_OQ8]UK6&G<\2(3[G%6$TN3'0'Z M5+F3R29B?88R/DDP?0T?8;B/[N2/:N@&E'&65A_P&AK;R^%W?E4^T0O9OJ<[ MEHSAXP?TI#)$PZ[3[UNO;$_ZR,$?[1 JG-8VIZDJ?:K4T2TT9OE!QVQZ]:JW M%@#SM!K1>U6(YB0M[L_^%5VN[B,E7C51VP,?K5)@GW,>33G)RH('O4#6#(,O M(H'MS6G)3:?IAO-5M+-F*K/,L991D@$XS4-W;W&D:I/ 'DBFMY60.I*G@][A1I--OTN,;01LE4JTI GS8;B'8X &2002& K>^+ MS-_;6GH3\HMR0/0EC_@*Y2U\7ZM8^'Y=$@F1;.0,OW/F ;J ??)JX.I."G%Z MO[K$S5.$W!K;\S7\,>!K;Q1$\MOK#((=OG(;;!!(Z [N>AYKDX+&>\U%;*U1 MI9I)-B*.I->H?!S_ (]=7_WXOY-61\+;.&?Q=?7$A!D@B;RU/7+-@G\N/QJ7 M6E!U+ZV&J,9QIVTN8NIZ!HV@7:6&JZG=->[091:PADASTR6(+>O%5-?\+3:! M>6OVFY$FG76&BO(D)!7K]WUP>=9=K2)>% V !T MV'%1:[XUCUGPQ!H@TA;>.W$8AE:XWLFT8'&T=LC\:J$JKY7WWV_ 4XTUS+MM M_P $LVGPW&H^'3J^GZK]H1P?*C>'RLD-M)8EC@#D_A5+3-"\)W6HQZ7-K=Z] MW*PC6>&$" N> H)Y//&< 5V%B=GP,EPQ_P!5("5/_34UYGX=*_\ "3:7A"?] M+BY)_P!L5,)3FIWEM>Q4U"+A:.]B_KWA?_A&_$"Z?J%Z5M9$\R.Y2'>2O/\ M#DC,(1C*G.5MB#X40Z=%JEXUK>233&V7S(VM]FSD=\G/- MJMJ9NC+*B(@AV M !@3D\GTK-T7P;)?Z//KFI70T_2(>LQ3<\ASC"+D9YX^OK7H_P 4?^2=6/\ MUVA_] :H/B# EE\*M,MK<;8PT"X'<;"?Y\U$,1.48IO5NWR*G0A&4G;1*YP> MD^&-*\37,MEHE[?+>)&9%%W NQP.Q96.W\17*W$,EK/K2;@/4TS)I* /2 M_@JV?&-X, ?\2]^G_72.O=J\&^"G_(YWG_8/?_T9'7O->-COXWR1[.!_@_-G M-:K\/_"^MZE-J.HZ6L]W-C?(99%S@!1P& Z 52_X55X*_P"@(G_?^7_XJNRH MKFYY=SIY(]CC?^%4^"O^@(G_ '_E_P#BJ/\ A57@K_H")_W_ )?_ (JNRHHY MY=QQQO_"JO!?_ $!%_P"_\O\ \52_\*K\%_\ 0$3_ +_R_P#Q5=C11SR[ MA[./8X[_ (57X+_Z B?]_P"7_P"*H_X57X+_ .@*O_?^7_XJNQHI^TGW#DCV M.._X59X,_P"@*O\ W_E_^*H_X59X,_Z J_\ ?^7_ .*KL:*7//N'LX]CD1\, M?!ZC T@ ?]?$O_Q5+_PK+PC_ - D?^!$O_Q5=;13]I/N'LX=CD3\,O"##!T@ M$?\ 7Q+_ /%4@^%_@X=-''_@1+_\577T4>TGW#V<>QQ__"KO!O\ T!E_\")? M_BJ/^%7>#?\ H#+_ -_Y?_BJ["BCVD^X>SCV.0_X5=X-_P"@,O\ W_E_^*I/ M^%7>#O\ H#+_ -_Y?_BJ["BCVD^X>SAV./\ ^%7>#O\ H#K_ -_Y?_BJ7_A5 M_@[_ * P_P# B7_XJNOHH]I/N'LX]CD/^%7^#O\ H#C_ ,")?_BJ/^%7^#O^ M@./_ (E_P#BJZ^BCVD^X>SAV.0_X5?X._Z X_\ B7_ .*H_P"%7^#O^@.O M_@1+_P#%5U]%'M)]P]G#LND#_P(E_\ MBJZZBCVD^[#V<.QR/_"L?!^?^00/_ B7_P"*I?\ A67A'_H$_P#DQ+_\576T M4>TGW8>SAV.2_P"%9>$/^@3_ .3$O_Q5(?AEX0/72!_X$2__ !5==11[2?=A M[.'8Y'_A6/@__H$#_P ")?\ XJC_ (5CX/\ ^@0/_ B7_P"*KKJ*/:3[L/9P M['(_\*Q\'_\ 0('_ ($2_P#Q5'_"L?"'_0('_@1+_P#%5UU%'M)]V'LX=CD? M^%8^#_\ H$#_ ,")?_BJ/^%8^$/^@0/_ (E_P#BJZZBCVD^[#V<.QR/_"LO M"'_0('_@1+_\52_\*R\(_P#0)_\ )B7_ .*KK:*/:3[L/9P[')?\*S\(_P#0 M)_\ )B7_ .*I?^%:>$?^@3_Y,2__ !5=911[2?=A[.'8Y/\ X5IX2_Z!7_DQ M+_\ %4X?#CPJO33"/IUGW8O90[(Y7_ (5QX5_Z!A_\")?_ (JC_A7'A7_H&'_P)E_^*KJJ M*/:S[L/90[(Y7_A7'A7_ *!9_P# B7_XJC_A7'A7_H&'_P "9?\ XJNJHH]K M/^9A[*'9'+?\*Y\+?] P_P#@3+_\51_PKKPM_P! UO\ P)E_^*KJ:*/:S_F8 M>RI]DUG_,P M]E#LCF1\/O#*]-/UG_ #,/94_Y M4UG_ #/[P]E3 M_E1A_P#"(:,.D,__ (%S?_%5(OA?2E'$$GU,\A_FU;%%'M9]V'LH=D9!\-V! MZ!Q]#43^&X!_JI6'^\,UN44_;5%U$Z--]#FWT.5>JB1?8Y_G48TZ.-L8=#]* MZ?%(\:N,, 1[U:KRZD/#0Z'/BTD ^63(]Z:\$P'(4_7%;WV=!]T4-""*/;$_ M5SEI;?).ZW4_2J%Q:P8^:)U^E=5<6*MG@#WK(N=/<9\N4#V)Q71"JF7= X$.]4;'2?,:R@= M"&/&?YUS$FCP,=T4LBGW%0-IMPGW953@CD_\ ?(X] MJSFM9AUC_(YJ(VDA./+;\J?LKRYINXO:6C:*L=?XH%IX[M+*_P!,O+>*]A0I M-:7$HC;!YXSP<'//3FN:^PVGANSN9+F[M;G4YHFAB@A82+#N&&=FZ9 R /4U M1DL\?>P/8\_RJJ]I'_TT)]A@5$:+BN5/0J592?,UJ>B_#N[TWPY;7ZW^K:>I MN&0H%N%/0'/\ZY'1-6/A#Q;'>&2"Y@D!64VT@?*,?7U! ./:L%H"O2+(_$TP ML5[8_"CZNKR;=^;;VQ7UCWG)K?*KVXM]4TTQ7ES-+&_VI<*N[ M(W'MD&N;*A?O$+^IIID ^ZOXM0J+4W.^K$ZR<%"VQ[1XVU#2]?\ "-MI]EK& MFM<1R1LVZX4#A2#S^-9,>L6'BOP.OAN]U"VM-4LRHADF?;%+LX&&]QQ^M>5, M[-U.:42<;6Y%0L*HQM?9W-'BFY7MNK'6V_AR+1;I;W7+VQ%M =XM[>=99;@C MHH Z ]R>@KE+ZZ>]OKB[D55>:1I"JC !)S@>U,:/C*\BF;CWY^M;QBT[MW9A M*2:LE892&I, ]B*0ICOGZ59!&:7'K1G':DYH ])^"G_(YWG_ &#W_P#1D=>\ M5X-\$_\ D<[S_L'O_P"C(Z]YKQL=_&^2/9P/\'YL****Y#K"BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J72E4+ M $COBL2>X/.U\_C738K$UC2I)(S-9A3*.3&?XOI[UM2FD[,YJ\)6O$Q9;IB3 M\JG\*SKCR9?OP@'U5L52EUEHY&BN(,,IP5)((J(ZS8'[WF1GV.17IQA8\MU4 M]&R1[&(DLDCCV85FSP>4QVNOU.:T%N(9D+QS@K[C%56*L2?,5O93S6T7W):O ML9S>7!5HK>28Q>>OF JI(RHR>P]ZGT_Q+<1+(NIR37"J4EAWG?B16!QST MR,BF/J>D6\U_<*\LSW,,B(IA"[2P_B.>?2N>]5+E?WFUJ3?,99MKY[TV;1B. M7R_.R'&W9MW[MWIBHET[4)X6DM+V"5EC,IC6=2P4#)X]AVJY)KUB^BK$891> MF,6KLIX\@-NP#Z]!]!5E=:TRWEN#9RF*VEMY8D@2V52NY2!N8'+8)[D^M6YU M.PE"GW*$&EZXWD!TMBUP@>%'G17D!&1@9IUO:7,MJES<)%;0NQ5&GF6/>0<' M /IZU*-5LUUS2[LSGR+1(%;(PWR 9Q^(-17]QIFMVML)KB:WN+=#&0J!U==Q M((^88//-'-4Z[>@X8S7L2^9+%Y6["N M<*,DG&1D^_YY^BZBME.\LFHR6^<*4\CS5E7^)6&1^7\JI3DXMK?T)<(J23*J M:-=S1R3?:;)($D\KSI9%5'?&<*?XN/3I2_V)>SQV:VL4;R3122LYD39M5RI; M.!M48ZDUHW>HZ)J=I]D<36<4%S+);_NO,!C?'!Y&&&/>K%AXBTZRM[:W(N(H M_P"SWM))44%T8RF3*@GD']5GN+>&WCMKC[1O$3PR*R ML5&6&<]0.Q]122^'M52&.6.*VN5>40_Z-(DI5SR%.T]3S^5:4>OV]K=HS:I/ M=HD,^P- (PDCQE%(&?<9-0>'/$,>A0>8R&XF%[%/L! !15<'GL?GXIN56UPY M:=[7*LN@ZA#<1VP6UFNG?888ID9D."3NYX P2WD8H) M8)%==PY*G'0X(-:]GJ6FZ-KK7]M=7D\,XEC=6@"R1*ZD9!+$%@3^.*SM:U1K MB"."+5Y[V(.7*O;B(*<8!X)R2,__ %Z<95')+IZ"E&"BVBWH>DV]YHE_J=V$ MD$#I%'"MRD+%F#'/S YZ< #DY]*IW'A_4K6"=WCMFDMUWSP),C2Q#U90/J*N>'?$.GZ5;Z>LZR[X-3^U/M7(V!,#'/7.:;=3V:?424.=KH2 M6_A^)?#/V]E6>\N+AH+>&*[C4J0%QE<$NV6Y48XY[U0DT6:V/G7'V>2".58[ MDV\Z,8B3T8C..AYY'%6[+Q19Z?9Z 5BDDGL+V6YG0CA@Q7&#ZX!_&J^M:O%/ M:R1VNM7=Q%+("8);58\+R1N(/)!QT^M2G4YK,N7L[719N-.\.?89)HM2D69$ MF_5@A1P0AS_O+ZUROF'T'Y4[*.,%OTIC)M/WA6T(N.[N82E?I80R MD]A^5&_V _"D(]Q^=)M-62>D?!0Y\97G3_D'O_Z,CKWBO!O@FI'C.\S_ - ] M_P#T9'7O->-COXWR1[.!_@_-A1117(=84444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@>(/"UGKL89B8;D# MY9D')]B.XKR/Q!I]_P"'KOR+JVVJ3^[F^\K_ $/].M>]U6OK"UU&U:VO($FA M?JCC(_\ UUTT,5*EH]4 M([7.@2>?'U^S2, Z_P"ZQX/XX_&O,+ZUO--NFMKZVEMYEZI*I4__ *J]:E5A M47NL\NI2G3TDC?BULYQN93]:M+JKD?ZP,/?FN/%QMZ4?:FS]ZM+(SNSLO[47 MH44_I44EQ;2#E2I]C7++?..IS4GV[/4XI(.,%3Z]::75N1)^8K/,N>HI"_H:8BZW^\IJ)E M/;]*K>:12^90!*6D7N<4WS">M,\P^IIID)H DW+W%)O':HRU)NH D.3WIO-, M+"C=QP30 _-)FF[OH:,^U #MU.#Y>:3.: )#@4TFDS2&@#TKX(G/C.\_[ M![_^C(Z][KP3X(_\CI>?]@]__1D=>]UXV._C?)'LX'^#\V%%%%C/-M5^"^@W MA9["YNK!C_"#YB#\&Y_6N5O/@CJT>3::K:3 ?\]$=#^FZO)H6V^7$_N@D(_] J/_ (5AXF_Y]Q_WQ)_\17TE16OUZJ9_4:9\ MV_\ "L?$_P#S[C_OB3_XBC_A67B?_GW'_?$G_P 17TE11]>J!]1IGS;_ ,*Q M\3_\^X_[XD_^(I?^%9>)O^?JA]1IGS9_P *P\3?\^X_[XD_^(H_X5?XF_Y]Q_WQ M)_\ $5])T4?7JH?4:9\V?\*O\3?\^X_[XD_^(H_X5AXF_P"?J!]1IGS9_PJ_Q-_P ^X_[XD_\ B*/^%7^)O^?FT0(5Q\Q=#W4=@:] XML 8 tm218538d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000885725 2021-03-03 2021-03-03 0000885725 us-gaap:CommonStockMember 2021-03-03 2021-03-03 0000885725 bsx:SeniorNoteDue2027Member 2021-03-03 2021-03-03 0000885725 bsx:A550MCPSSeriesAMember 2021-03-03 2021-03-03 iso4217:USD shares iso4217:USD shares 0000885725 false 8-K 2021-03-03 BOSTON SCIENTIFIC CORPORATION DE 1-11083 04-2695240 300 Boston Scientific Way Marlborough MA 01752-1234 508 683-4000 false false false false Common Stock, $0.01 par value per share BSX NYSE 0.625% Senior Notes due 2027 BSX27 NYSE 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share BSX PR A NYSE false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover
Mar. 03, 2021
Entity Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 03, 2021
Entity File Number 1-11083
Entity Registrant Name BOSTON SCIENTIFIC CORPORATION
Entity Central Index Key 0000885725
Entity Tax Identification Number 04-2695240
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 300 Boston Scientific Way
Entity Address, City or Town Marlborough
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01752-1234
City Area Code 508
Local Phone Number 683-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol BSX
Security Exchange Name NYSE
Senior Note due 2027 [Member]  
Entity Information [Line Items]  
Title of 12(b) Security 0.625% Senior Notes due 2027
Trading Symbol BSX27
Security Exchange Name NYSE
5.50% MCPS, Series A [Member]  
Entity Information [Line Items]  
Title of 12(b) Security 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share
Trading Symbol BSX PR A
Security Exchange Name NYSE
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 4 96 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://bostonscientific.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm218538d1_8k.htm bsx-20210303.xsd bsx-20210303_def.xml bsx-20210303_lab.xml bsx-20210303_pre.xml tm218538d1_ex99-1.htm http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm218538d1_8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "bsx-20210303_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm218538d1_8k.htm" ] }, "labelLink": { "local": [ "bsx-20210303_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "bsx-20210303_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "bsx-20210303.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 2, "memberStandard": 1, "nsprefix": "bsx", "nsuri": "http://bostonscientific.com/20210303", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm218538d1_8k.htm", "contextRef": "From2021-03-03to2021-03-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://bostonscientific.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm218538d1_8k.htm", "contextRef": "From2021-03-03to2021-03-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "bsx_A550MCPSSeriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "5.50% MCPS, Series A [Member]" } } }, "localname": "A550MCPSSeriesAMember", "nsuri": "http://bostonscientific.com/20210303", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "domainItemType" }, "bsx_SeniorNoteDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Note due 2027 [Member]" } } }, "localname": "SeniorNoteDue2027Member", "nsuri": "http://bostonscientific.com/20210303", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://bostonscientific.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 16 0001104659-21-031097-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-031097-xbrl.zip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�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end